The role of diffusion tensor imaging for the assessment of liver fibrosis and inflammation in chronic viral hepatitis: A preliminary study
Objective: To evaluate the role of magnetic resonance (MR) diffusion tensor imaging (DTI) in the assessment of liver fibrosis andinflammation in chronic viral hepatitis by measuring apparent diffusion coefficient (ADC) and fractional anisotropy (Fa) values.Material and Methods: Twenty-seven patients (5 women and 22 men;mean age39.8±11.3) with hepatic fibrosis were included inour study. The relationship between ADC, Fa values and histological activity index (HAI) score were evaluated using Spearman’scorrelation coefficient. Patients were subgrouped as group A (fibrosis score 1) and group B (fibrosis score 3). The mean ADC and Favalues of groups A and B were compared using Student’s t-test. To evaluate the use of ADC and Fa values in distinguishing group Afrom group B, ROC analysis was applied; sensitivities and specificities were calculated.Results: Fa values correlated with HAI scores significantly (r=0.397, p<0.05) The difference was significant between the mean ADCvalues (group A:1.46± 0.191x103mm2/s; group B:1.105± 0.141x10-3 mm2/s; p<0.001) and Fa values (group A: 0.473±0.091; groupB: 0.643± 0.007; p<0.001) between the groups. For distinguishing group A from group B, ADC had a sensitivity of 81.8% and aspecificity of 93.8%. The sensitivity and specificity of Fa were 90.9% and 100%, respectively.Conclusion: Diffusion tensor imaging may play a role in the evaluation of fibrosis and HAI scores in patients with liver fibrosis.
___
- [1] Taouli B, Chouli M, Martin AJ, et al. Chronic hepatitis: role of
diffusion weighted imaging and diffusion tensor imaging for
the diagnosis of liver fibrosis and inflammation. J Magn Reson
Imaging 2008; 28:89-95. doi.org/10.1002/jmri.21227.
- [2] Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P,
Van Beers BE. Assessment of diffusion-weighted MR imaging
in liver fibrosis. J Magn Reson Imaging 2007; 25:122-8.
doi:10.1002/jmri.20771.
- [3] Aguirre DA, Behling CA, Alpert E, Hassanein TI, Sirlin CB.
Liver fibrosis: noninvasive diagnosis with double contrast
material-enhanced MR imaging. Radiology 2006;239:425-37.
doi.org/10.1148/radiol. 239.205.0505.
- [4] Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted
magnetic resonance ımaging for the staging of liver
fibrosis. J Clin Gastroenterol 2011;45:885-92. doi: 10.1097/
MCG.0b013e318223bd2c.
- [5] Sandrasegaran K, Fatih M, Akisik FM, et al. Value of diffusionweighted
MRI for assessing liver fibrosis and cirrhosis. Am J
Roentgenol 2009;193:1556-60. doi:10.2214/AJR.09.2436
- [6] Koinuma MN, Ohashi I, Hanafusa K, et al. Apparent diffusion
coefficient measurements with diffusion-weighted magnetic
resonance imaging for evaluation of hepatic fibrosis. J Magn
Reson Imaging 2005;22:80-5.doi. org/10.1002/jmri.20344.
- [7] 7. Taouli B, Toila AJ, Losada M, et al. Diffusion-weighted MRI
for quantification of liver fibrosis: preliminary experience. Am
J Roentgenol 2007;189:799-806. doi:10.2214/AJR.07.2086.
- [8] 8. Girometti R, Furlan A, Bazzocchi M, etal. Diffusionweighted
MRI in evaluating liver fibrosis: a feasibility study in cirrhotic
patients. Radiol Med 2007;112:394-408. doi: 10.1007/
s11547.007.0149-1.
- [9] Soylu A, Kılıçkesmez Ö, Poturoğlu Ş, et.al. Utility of diffusionweighted
MRI for assessing liver fibrosis in patients with
chronic active hepatitis. Diagn Interv Radiol 2010; 16:204-8.
doi: 10.4261/1305-3825.DIR. 2810-09.1.
[10] Bakan AA, Inci E, Bakan S, Gokturk S, Cimilli T. Utility of
diffusion-weighted imaging in the evaluation of liver fibrosis.
EurRadiol 2012;22: 682-7. doi:10.1007/s00330.011.2295-z.
- [11] Taouli B, Martin AJ, Qayyum A, Merriman RB, et.al. Parallel
imaging and diffusion tensor imaging for diffusion-weighted
MRI of the liver: Preliminary experience in healthy volunteers.
AJR Am J Roentgenol 2004;183:677-80. doi: 10.2214/
ajr.183.3.1830677.
- [12] Knodell RG, Ishak KG, Black WC, et al. Formulation and
application of a numerical scoring system for assessing
histological activity in asymptomatic chronic active hepatitis.
Hepatology 1981;1:431-5. doi.org/ 10.1002/hep.184.001.0511.
- [13] Marcellin P, Asselah T, Boyer N. Fibrosis and disease
progression in hepatitis C. Hepatology 2002; 36:47-56. doi:
10.1053/jhep.2002.36993.
- [14] Davis JA. Elementary survey analysis. Englewood Cliffs, NJ:
Prentice-Hall,1971:49.
- [15] Shiffman ML, Benhamou Y. Patients with HCV and F1 and
F2 fibrosis stage:treat now or wait? Liver Int 2013; 33:105-10.
doi: 10.1111/liv.12066.
- [16] Tosun M, Inan N, Sarisoy HT, et.al. Diagnostic performance of
conventional diffusion weighted imaging and diffusion tensor
imaging for the liver fibrosis and inflammation. Eur J Radiol.
2013;82(2):203-7. doi: 10.1016/j.ejrad.2012.09.009.